Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

RNase L levels in peripheral blood mononuclear cells: 37-kilodalton/83-kilodalton isoform ratio is a potential test for chronic fatigue syndrome.

Tiev KP, Demettre E, Ercolano P, Bastide L, Lebleu B, Cabane J.

Clin Diagn Lab Immunol. 2003 Mar;10(2):315-6.

2.

Variability of the RNase L isoform ratio (37 kiloDaltons/83 kiloDaltons) in diagnosis of chronic fatigue syndrome.

Tiev KP, Briant M, Ziani M, Cabane J, Demettre E, Lebleu B.

Clin Diagn Lab Immunol. 2005 Feb;12(2):366. No abstract available.

3.

37-Kilodalton/83-kilodalton RNase L isoform ratio in peripheral blood mononuclear cells: analytical performance and relevance for chronic fatigue syndrome.

Frémont M, Vaeyens F, Herst CV, De Meirleir K, Englebienne P.

Clin Diagn Lab Immunol. 2005 Oct;12(10):1259-60; author reply 1260. No abstract available.

4.

Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome.

Suhadolnik RJ, Peterson DL, O'Brien K, Cheney PR, Herst CV, Reichenbach NL, Kon N, Horvath SE, Iacono KT, Adelson ME, De Meirleir K, De Becker P, Charubala R, Pfleiderer W.

J Interferon Cytokine Res. 1997 Jul;17(7):377-85.

PMID:
9243369
5.

2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.

Frémont M, El Bakkouri K, Vaeyens F, Herst CV, De Meirleir K, Englebienne P.

Exp Mol Pathol. 2005 Jun;78(3):239-46.

PMID:
15924878
6.

Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome.

Nijs J, De Meirleir K.

In Vivo. 2005 Nov-Dec;19(6):1013-21. Review.

7.

Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome.

Shetzline SE, Martinand-Mari C, Reichenbach NL, Buletic Z, Lebleu B, Pfleiderer W, Charubala R, De Meirleir K, De Becker P, Peterson DL, Herst CV, Englebienne P, Suhadolnik RJ.

J Interferon Cytokine Res. 2002 Apr;22(4):443-56.

PMID:
12034027
8.

A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome.

De Meirleir K, Bisbal C, Campine I, De Becker P, Salehzada T, Demettre E, Lebleu B.

Am J Med. 2000 Feb;108(2):99-105.

PMID:
11126321
10.

Characterization of a 2',5'-oligoadenylate (2-5A)-dependent 37-kDa RNase L: azido photoaffinity labeling and 2-5A-dependent activation.

Shetzline SE, Suhadolnik RJ.

J Biol Chem. 2001 Jun 29;276(26):23707-11. Erratum in: J Biol Chem 2001 Aug 24;276(34):32392.

11.

Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables.

Borish L, Schmaling K, DiClementi JD, Streib J, Negri J, Jones JF.

J Allergy Clin Immunol. 1998 Aug;102(2):222-30.

PMID:
9723665
12.
13.

Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.

Maloney EM, Boneva R, Nater UM, Reeves WC.

Psychosom Med. 2009 Jun;71(5):549-56. doi: 10.1097/PSY.0b013e3181a4fea8.

PMID:
19414615
14.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
15.

Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.

Raison CL, Lin JM, Reeves WC.

Brain Behav Immun. 2009 Mar;23(3):327-37. doi: 10.1016/j.bbi.2008.11.005.

PMID:
19111923
16.

Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance.

Meeus M, Nijs J, McGregor N, Meeusen R, De Schutter G, Truijen S, Frémont M, Van Hoof E, De Meirleir K.

In Vivo. 2008 Jan-Feb;22(1):115-21.

17.

Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States.

Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, Reeves WC, Heneine W.

Retrovirology. 2010 Jul 1;7:57. doi: 10.1186/1742-4690-7-57.

18.

Clinical laboratory test findings in patients with chronic fatigue syndrome.

Bates DW, Buchwald D, Lee J, Kith P, Doolittle T, Rutherford C, Churchill WH, Schur PH, Wener M, Wybenga D, et al.

Arch Intern Med. 1995 Jan 9;155(1):97-103.

PMID:
7632202
19.

Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.

Maloney EM, Boneva RS, Lin JM, Reeves WC.

Metabolism. 2010 Sep;59(9):1351-7. doi: 10.1016/j.metabol.2009.12.019.

PMID:
20102774
20.

Diagnostic accuracy of symptoms characterising chronic fatigue syndrome.

Davenport TE, Stevens SR, Baroni K, Van Ness M, Snell CR.

Disabil Rehabil. 2011;33(19-20):1768-75. doi: 10.3109/09638288.2010.546936.

PMID:
21208154
Items per page

Supplemental Content

Support Center